China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999

Watchlist Manager
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Logo
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999
Watchlist
Price: 45.69 CNY -3.75% Market Closed
Market Cap: 58.3B CNY
Have any thoughts about
China Resources Sanjiu Medical & Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
China Resources Sanjiu Medical & Pharmaceutical Co Ltd

Wall Street analysts forecast China Resources Sanjiu Medical & Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Resources Sanjiu Medical & Pharmaceutical Co Ltd is 56.45 CNY with a low forecast of 36.36 CNY and a high forecast of 65.1 CNY.

Lowest
Price Target
36.36 CNY
20% Downside
Average
Price Target
56.45 CNY
24% Upside
Highest
Price Target
65.1 CNY
42% Upside
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors:
Price Targets
SUPN
Supernus Pharmaceuticals Inc
11% Upside
300723
Yipinhong Pharmaceutical Co Ltd
68% Upside
GLS
Glenmark Life Sciences Ltd
5% Upside
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
40% Upside
ZVRA
Zevra Therapeutics Inc
123% Upside
600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
26% Upside
LUPIN
Lupin Ltd
7% Upside
603707
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
55% Upside

Revenue
Forecast

Revenue Estimate
China Resources Sanjiu Medical & Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for China Resources Sanjiu Medical & Pharmaceutical Co Ltd's revenue is 15%. The projected CAGR for the next 3 years is 12%.

15%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
China Resources Sanjiu Medical & Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for China Resources Sanjiu Medical & Pharmaceutical Co Ltd's operating income is 15%. The projected CAGR for the next 3 years is 16%.

15%
Past Growth
16%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
China Resources Sanjiu Medical & Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for China Resources Sanjiu Medical & Pharmaceutical Co Ltd's net income is 11%. The projected CAGR for the next 3 years is 16%.

11%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-25%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is China Resources Sanjiu Medical & Pharmaceutical Co Ltd's stock price target?
Price Target
56.45 CNY

According to Wall Street analysts, the average 1-year price target for China Resources Sanjiu Medical & Pharmaceutical Co Ltd is 56.45 CNY with a low forecast of 36.36 CNY and a high forecast of 65.1 CNY.

What is China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for China Resources Sanjiu Medical & Pharmaceutical Co Ltd's revenue is 15%. The projected CAGR for the next 3 years is 12%.

What is China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for China Resources Sanjiu Medical & Pharmaceutical Co Ltd's operating income is 15%. The projected CAGR for the next 3 years is 16%.

What is China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for China Resources Sanjiu Medical & Pharmaceutical Co Ltd's net income is 11%. The projected CAGR for the next 3 years is 16%.

Back to Top